330 related articles for article (PubMed ID: 23400693)
1. Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
Zhu H; Cao J; Cui S; Qian Z; Gu Y
J Pharm Sci; 2013 Apr; 102(4):1318-32. PubMed ID: 23400693
[TBL] [Abstract][Full Text] [Related]
2. A polymeric micelle with an endosomal pH-sensitivity for intracellular delivery and enhanced antitumor efficacy of hydroxycamptothecin.
Pu X; Zhao L; Li J; Song R; Wang Y; Yu K; Hou X; Qiao P; Zong L; Chang S
Acta Biomater; 2019 Apr; 88():357-369. PubMed ID: 30822554
[TBL] [Abstract][Full Text] [Related]
3. A study of the synergistic effect of folate-decorated polymeric micelles incorporating Hydroxycamptothecin with radiotherapy on xenografted human cervical carcinoma.
You H; Fu S; Qin X; Yu Y; Yang B; Zhang G; Sun X; Feng Y; Chen Y; Wu J
Colloids Surf B Biointerfaces; 2016 Apr; 140():150-160. PubMed ID: 26752212
[TBL] [Abstract][Full Text] [Related]
4. Conjugates of TAT and folate with DOX-loaded chitosan micelles offer effective intracellular delivery ability.
Zhang S; Liu Y; Gan Y; Qiu N; Gu Y; Zhu H
Pharm Dev Technol; 2019 Feb; 24(2):253-261. PubMed ID: 29688120
[TBL] [Abstract][Full Text] [Related]
5. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyethyl starch conjugates for improving the stability, pharmacokinetic behavior and antitumor activity of 10-hydroxy camptothecin.
Li G; Li Y; Tang Y; Zhang Y; Zhang Y; Yin T; Xu H; Cai C; Tang X
Int J Pharm; 2014 Aug; 471(1-2):234-44. PubMed ID: 24861941
[TBL] [Abstract][Full Text] [Related]
7. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
[TBL] [Abstract][Full Text] [Related]
8. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting.
Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z
Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739
[TBL] [Abstract][Full Text] [Related]
9. Nanomicelle Based Peroral Delivery System for Enhanced Absorption and Sustained Release of 10-Hydrocamptothecin.
Tian Y; Shi C; Zhang X; Sun Y; Wang J; Zhang Y; Yang J; Wang L; Wang L; Mao S
J Biomed Nanotechnol; 2015 Feb; 11(2):262-73. PubMed ID: 26349302
[TBL] [Abstract][Full Text] [Related]
10. Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance.
Liu M; Chen D; Wang C; Chen X; Wen Z; Cao Y; He H
J Drug Target; 2015; 23(9):800-5. PubMed ID: 25766079
[TBL] [Abstract][Full Text] [Related]
11. Amphiphilic Hybrid Dendritic-Linear Molecules as Nanocarriers for Shape-Dependent Antitumor Drug Delivery.
Guo Y; Wang T; Zhao S; Han M; Dong Z; Wang X; Wang Y
Mol Pharm; 2018 Jul; 15(7):2665-2673. PubMed ID: 29782803
[TBL] [Abstract][Full Text] [Related]
12. Formulation of injectable glycyrrhizic acid-hydroxycamptothecin micelles as new generation of DNA topoisomerase I inhibitor for enhanced antitumor activity.
Cai J; Luo S; Lv X; Deng Y; Huang H; Zhao B; Zhang Q; Li G
Int J Pharm; 2019 Nov; 571():118693. PubMed ID: 31525442
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions.
Han M; Liu X; Guo Y; Wang Y; Wang X
Int J Pharm; 2013 Oct; 455(1-2):85-92. PubMed ID: 23928147
[TBL] [Abstract][Full Text] [Related]
14. Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect.
Wang A; Li S
BMC Biotechnol; 2008 May; 8():46. PubMed ID: 18454874
[TBL] [Abstract][Full Text] [Related]
15. Lysine-mediated hydroxyethyl starch-10-hydroxy camptothecin micelles for the treatment of liver cancer.
Li G; Zhao M; Zhao L
Drug Deliv; 2020 Dec; 27(1):519-529. PubMed ID: 32228107
[TBL] [Abstract][Full Text] [Related]
16. Polymeric micelle systems of hydroxycamptothecin based on amphiphilic N-alkyl-N-trimethyl chitosan derivatives.
Zhang C; Ding Y; Yu LL; Ping Q
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):192-9. PubMed ID: 17223019
[TBL] [Abstract][Full Text] [Related]
17. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.
Li Q; Liu C; Zhao X; Zu Y; Wang Y; Zhang B; Zhao D; Zhao Q; Su L; Gao Y; Sun B
Int J Nanomedicine; 2011; 6():397-405. PubMed ID: 21499429
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of hydroxycamptothecin-loaded poly[ethylene glycol]-poly [gamma-benzyl-L-glutamate] micelles against oral squamous cell carcinoma.
Ding XQ; Chen D; Wang AX; Li S; Chen Y; Wang J
Oncol Res; 2007; 16(7):313-23. PubMed ID: 17518269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
